169262 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for cancer; Specifically defined cancers of lung
Combinations of ET-18-O-CHand anti-cancer agents for the treatment of cancer
#902METHODS FOR SCREENING FOR THERAPEUTIC MOLECULES AND USE OF THE MOLECULES THEREFROM
#903PROTEINS
#904PROTEINS
#905Protein
#906Lung cancer diagnotic assay
#907PROTEIN KINASE C IOTA
#908Protein Complex and Uses
#909Diagnosis and Treatment of Cancer Using Anti-Desmoglein-3 Antibodies
#910BRM EXPRESSION AND RELATED DIAGNOSTICS
#911Lung cancer detection by optical analysis of body fluids
#912Methods, assays and kits for cancer diagnosis and screening utilizing glycan-binding and glycan epitopes
#913Lung cancer biomarkers and uses thereof
#914Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Lung Cancer
#915METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#916Methods and compositions for treating and diagnosing diseases
#917Nucleic acids encoding IL-17 homologous receptor-like polypeptides and therapeutic uses thereof
#918Method for diagnosing non-small cell lung carcinoma
#919ASSESSING LUNG NODULES
#920Diagnostic tests using gene expression ratios
#921Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
#922Lung cancer evaluating apparatus, method, system, and program and recording medium therefor
#923DIAGNOSTIC AGENT FOR TUMOR
#924CTIP2 expression in squamous cell carcinoma
#925Lung-Expressed Polypeptides
#926Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof
#927Methods and compositions for diagnosing prostate cancer
#928Predicting response to a HER inhibitor
#929METHOD FOR IDENTIFYING THERAPEUTICAL TARGETS IN TUMORS, THE USE THEREOF AND MEANS FOR DETERMINING AND TARGETING ANGIOGENESIS AND HEMOSTASIS RELATED TO ANDENOCARCINOMAS OF THE LUNG
#930P450RAI-2 (P450 CYTOCHROME 26B), ENCODING NUCLEIC ACID MOLECULES AND METHODS AND USES THEREOF
#931Identification of Biomarkers Predictive of Dasatinib Effects in Cancer Cells
#932Antibodies to PRO352
#933IL-17 homologous polypeptides and therapeutic uses thereof
#934Asbestos exposure, pleural mesothelioma, and osteopontin levels
#935In vitro method for identifying compounds for cancer therapy
#936Arginase II: A Target treatment of aging heart and heart failure
#937METHODS FOR THE DIAGNOSIS OF LUNG CANCER
#938NON-SMALL CELL LUNG CANCER-RELATED GENE, ANLN, AND ITS INTERACTION WITH RhoA
#939Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
#940Methods and Compositions for the Prediction of Response to Trastuzumab Containing Chemotherapy Regimen in Malignant Neoplasia
#941Measurement of nicotinamde N-methyl transferase in diagnosis of lung cancer
#942Method for determining a lung cancer treatment and method for determining the effectiveness of an agent for treatment of lung cancer
#943Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors
#944Odontogenic ameloblast-associated protein as a tumor biomarker
#945IDENTIFICATION OF PROTEIN ASSOCIATED WITH HEPATOCELLULAR CARCINOMA, GLIOBLASTOMA AND LUNG CANCER
#946PROTEIN
#947UHRF1 DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#948TTK DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#949LUNG DISEASE TARGETS AND USES THEREOF
#950NUCLEIC ACIDS ENCODING RECEPTOR FOR IL-17 HOMOLOGOUS POLYPEPTIDES AND USES THEREOF
#951Method for Identifying, Marking and Treating Epithelial Lung Tumour Cells and Means for Carrying Out Said Method
#952Screening and therapeutic method for NSCLC targeting CDCA1-KNTC2 complex
#953ERCC1 EXPRESSION IN PREDICTING RESPONSE FOR CANCER CHEMOTHERAPY
#954Bone morphogenetic protein-2 in the treatment and diagnosis of cancer
#955Antibody directed against PAP2a and use thereof for diagnostic and therapeutic purposes
#956Cytotoxicity mediation of cells evidencing surface expression of CD44
#957LUNG CANCER BIOMARKERS
#958Lung Cancer Diagnostic Assay
#959Methods and compositions for treating diseases targeting CDCP1
#960IDENTIFICATION OF NOVEL PATHWAYS FOR DRUG DEVELOPMENT FOR LUNG DISEASE
#961Methods for treating lung cancers
#962FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME
#963Lung cancer markers, and uses thereof
#964AIMP2-DX2 gene and SiRNA targeting AIMP2-DX2
#965Gene defects and mutant ALK kinase in human solid tumors
#966C-MET MUTATIONS IN LUNG CANCER
#967Methods for the generation of cartilage-like material by mechanical loading
#968JAB1 as a prognostic marker and a therapeutic target for human cancer
#969Use of DKK-1 protein in the cancer diagnosis
#970Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis
#971METHODS, KITS, AND COMPOUNDS FOR DETERMINING RESPONSIVENESS TO TREATMENT OF A PATHOLOGICAL DISORDER BY EPOTHILONES
#972Cancer vaccine
#973METHOD OF IDENTIFYING PROTEINS IN HUMAN SERUM INDICATIVE OF PATHOLOGIES OF HUMAN LUNG TISSUES
#974Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues
#975STRATIFIN DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#976Compositions and methods for the therapy and diagnosis of lung cancer
#977DIAGNOSTIC AND PROGNOSTIC METHODS FOR LUNG DISORDERS USING GENE EXPRESSION PROFILES FROM NOSE EPITHELIAL CELLS
#978PRO1190 polypeptides
#979MONOCLONAL ANTIBODY, GENE ENCODING THE ANTIBODY, HYBRIDOMA, PHARMACEUTICAL COMPOSITION, AND DIAGNOSTIC REAGENT
#980LOX and LOXL2 inhibitors and uses thereof
#981AUTOANTIGEN BIOMARKERS FOR EARLY DIAGNOSIS OF LUNG ADENOCARCINOMA
#982Neoplasia-Specific tNOX Isoforms and Methods
#983Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLS)
#984Drug selection for lung cancer therapy using antibody-based arrays
#985Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC)
#986Compartment segregation by pixel characterization using image data clustering
#987Method for diagnosing cancer using cancer-associated deletion gene marker
#988Cancer Antigen Mage-A9 and Uses Thereof
#989METHOD FOR QUANTITATIVE MEASUREMENT OF GENE EXPRESSION FOR INDENTIFYING INDIVIDUALS AT RISK FOR BRONCHOGENIC CARCINOMA
#990Cancer Screening Test
#991COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
#992PIK4CA as modifier of the Rac pathway and methods of use
#993Preventive and/or Therapeutic Agent for Cancer
#994Cancer Test
#995oncogene as a prognostic indicator for lung cancer
#996SPHKS as modifiers of the p53 pathway and methods of use
#997Histone Deacetylase Inhibitors Sensitize Cancer Cells to Epidermal Growth Factor Inhibitors
#998Molecular Markers Associated with Bone Metastasis
#999Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors
#1000Peptide-conjugates that bind to VEGF-stimulated or tumor vasculature and methods of treatment
#1001Lung cancer-targeted peptides and applications thereof
#1002Antibody directed against gastrin-releasing peptide precursor and use thereof
#1003Materials and methods for prognosing lung cancer survival
#1004COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
#1005COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
#1006MARKs as Modifiers of the p53 Pathway and Methods of Use
#1007Methods and marker combinations for screening for predisposition to lung cancer
#1008IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#1009Cell-based detection and differentiation of disease states
#1010Weighted Scoring Methods and Use Thereof in Screening
#1011Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
#1012Method for diagnosing non-small cell lung cancers by tRNA-dihydrouridine synthase activity of
#1013SCDs As Modifiers of the p53 Pathway and Methods of Use
#1014Disease diagnostic system
#1015Polypeptide useful for cancer diagnosis and treatment
#1016Use Of Hedgehog Pathway Inhibitors In Small-Cell Lung Cancer
#1017Methods and compositions for diagnosing lung cancer
#1018Novel TWIK-6, TWIK-7, IC23927, TWIK-8, IC47611, IC47615, HNMDA-1, TWIK-9, alpha2delta-4, 8099, 46455, 54414, 53763, 97076, 97102, 44181, 67084Fl and 67084alt molecules and uses therefor
#1019Molecular based two-marker assays that predict outcome of adenocarcinoma patients
#1020Method of diagnosing lung cancer using BGS42
#1021Lung-Expressed Polypeptides
#1022Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk
#1023Protein kinase C iota
#1024Diagnostic methods for determining treatment
#1025PRO1477 polypeptides
#1026Diagnostics and Therapeutics for Diseases Associated with Tripeptidyl-Peptidase 2(Tpp2)
#1027PRO4356 polypeptides
#1028Tumor models employing green fluorescent protein
#1029TAT-046 and methods of assessing and treating cancer
#1030Cancer diagnosis and treatment of cancer using anti-robo 1 antibody
#1031TAT-042 and methods of assessing and treating cancer
#1032TAT-044 and methods of assessing and treating cancer
#1033TAT-039 and methods of assessing and treating cancer
#1034TAT-038 and methods of assessing and treating cancer
#1035TAT-028 and methods of assessing and treating cancer
#1036TAT-036 and methods of assessing and treating cancer
#1037TAT-030 and methods of assessing and treating cancer
#1038TAT-031 and methods of assessing and treating cancer
#1039Methods and marker combinations for screening for predisposition to lung cancer
#1040Antibodies as a cancer diagnostic
#1041HPRP4s modifiers of the p53 pathway and methods of use
#1042Method to evaluate the likelehood of development of bone metastasis based on the determination of calcium binding proteins
#1043Compositions and methods for the therapy and diagnosis of lung cancer
#1044Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-α
#1045Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
#1046Protein involved in carcinoma
#1047Method of screening for sensitivity to kinase inhibitor therapy
#1048Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
#1049PRO1298 polypeptides
#1050Alpha enolase-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance
#1051Diagnosis and treatment of tumor-suppressor associated disorders
#1052Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 85 (gpr85)
#1053Mammalian IAP gene family, primers, probes and detection methods
#1054Surface plasmon resonance biosensor system for detection of antigens and method for determining the presence of antigens
#1055Compositions and methods to diagnose and treat lung cancer
#1056Reagents and methods for use in cancer diagnosis, classification and therapy
#1057Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
#105826199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
#1059Differential transcript expression
#1060Marks as modifers of the PTEN pathway and methods of use
#1061Determination of responders to chemotherapy
#1062Cytotoxicity mediation of cells evidencing surface expression of CD44
#1063Mammalian IAP gene family, primers, probes and detection methods
#1064Mammalian IAP gene family, primers, probes and detection methods
#1065Annexin proteins and autoantibodies as serum markers for cancer
#1066Socs-3 promoter methylation in cancer
#1067Mammalian IAP gene family, primers, probes and detection methods
#1068Mammalian IAP gene family, primers, probes and detection methods
#1069Methods and compositions for treating diseases targeting CDCP1
#1070Mammalian IAP gene family, primers, probes and detection methods
#1071Mammalian IAP gene family, primers, probes and detection methods
#1072Mammalian IAP gene family, primers, probes and detection methods
#1073Bronchioalveolar stem cells and uses thereof
#1074IL-17 receptor-like polypeptides and therapeutic uses thereof
#1075Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
#1076Mammalian IAP gene family, primers, probes, and detection methods
#107714094, a novel human trypsin family member and uses thereof
#1078Method for cancer detection, progression analysis and malign tumour prognosis based on the study of metabolic markers of the cell
#1079Detection and treatment of cancers of the lung
#1080Methods of identifying active BRM expression-promoting HDAC inhibitors
#1081Methods for the identification, assessment, and treatment of patients with cancer therapy
#1082ANNEXIN PROTEINS AND AUTOANTIBODIES AS SERUM MARKERS FOR CANCER
#1083Gene markers for lung cancer
#1084P450RAI-2 (P450 cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof
#1085Method of diagnosing testicular tumors using polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, BGS42
#1086Methods and compositions for the modulation of immune responses and cancer diseases
#1087C-met mutations in lung cancer
#1088Methods and systems for diagnosis of non-central nervous system (cns) diseases in cns samples
#1089Method to detect lung cancer
#1090Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1091Monoclonal antibody and hybridoma producing the same
#1092Lung cancer prognostics
#1093Sphks as modifiers of the p53 pathway and methods of use
#1094Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1095Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1096Antibodies directed to the testis-specific tubulin tyrosine-ligase-like protein, BGS42
#1097Serum biomarkers in lung cancer
#1098Method for detecting carcinomas in a solubilized cervical body sample
#1099Methods for detecting vasculopathies and tumors
#1100Mammalian IAP gene family, primers, probes and detection methods
#1101Treatment of cancer using antibodies to polypeptides differentially expressed in human lung tumors
#1102Bone morphogenetic protein-2 in the treatment and diagnosis of cancer
#1103HLJ1 gene expression
#1104Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1105Anti-pro1477 antibodies
#1106Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a)
#1107LIMKs as modifiers of p53 pathway and methods of use
#1108Composition splice variants and methods relating to cancer specific genes and proteins
#1109Tubulin isotype screening in cancer therapy using hemiasterlin analogs
#1110Novel protein and gene encoding the same
#1111Method of screening for sensitivity to kinase inhibitor therapy
#1112Mammalian IAP gene family, primers, probes, and detection methods
#1113Sim2 polypeptides and polynucleotides and uses of each in diagnosis and treatment of ovarian, breast and lung cancers
#1114Insulin-like growth factor system and cancer
#1115Methods to diagnose and treat lung cancer
#1116AIMP2-DX2 and its uses
#1117PRO16090 antibodies
#1118Monoclonal antibody and gene encoding the same, hybridoma, pharmaceutical composition, and diagnostic reagent
#1119Protein involved in cancer
#1120Compositions comprising a lung tumor antigen
#1121Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1122PRO19624 antibodies
#1123PRO9835 antibodies
#1124Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1125Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1126Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1127Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1128Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1129Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1130Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1131Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1132Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1133Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
#1134Differential diagnosis of cancer and other conditions based on expression of p63
#1135Optimal polyvalent vaccine for cancer
#1136Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1137Serpentine transmembrane antigens expressed in human cancers and uses thereof
#1138Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1139Phage microarray profiling of the humoral response to disease
#1140Luminescence characterization of quantum dots conjugated with biomarkers for early cancer detection
#1141Reagents and methods for use in cancer diagnosis, classification and therapy
#1142Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1143Cell-based detection and differentiation of lung cancer
#1144Expression profiling in non-small cell lung cancer
#1145Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1146Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1147Compositions and methods for diagnosing, preventing, and treating cancers
#1148Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1149Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1150Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1151Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1152Human lung adenocarcinoma-related monoclonal antibody and antigen and immunaossay method which uses the same
#1153Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
#1154Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1155Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
#1156Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1157Early detection of cancer of specific type using 1HNMR metabonomics
#1158Chds as modifiers of the p53 pathway and methods of use
#1159Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1160Monoclonal antibodies and their use
#1161Method of diagnosing, monitoring, staging, imaging and treating cancer
#1162Methods for the detection of cervical cancer
#1163Human megakaryocyte-associated tyrosine kinase (MATK)-related gene variant associated with lung cancers
#1164Identification of a unique core domain of Par-4 sufficient for selective apoptosis induction in cancer cells
#1165Dgks as modifiers of the p53 pathwha and methods of use
#1166Cytotoxicity mediation of cells evidencing surface expression of CD44
#1167Protein markers for lung cancer and use thereof
#1168Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)
#1169JAB1 as a prognostic marker and a therapeutic target for human cancer
#1170Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)
#1171Human SGII-related gene variants associated with cancers
#1172Human ARL-related gene variants associated with cancers
#1173Human SACH-related gene variants associated with cancers
#1174Cancerous disease modifying antibodies
#1175Gene amplification and overexpression in cancer
#1176Cytotoxicity mediation of cells evidencing surface expression of CD44
#1177Serpentine transmembrane antigens expressed in human cancers and uses thereof
#1178Methods of treating cancer
#1179Method of treating lung cancer
#1180Method of treating lung cancer
#1181Oxidase activity of polymeric coated cerium oxide nano-particles